Tao Synergies Inc. Common Stock

TAOXNASDAQ • USD
4.41 USD
↗ 0.02 (0.46%)AT CLOSE (03:59 PM EDT)
4.50
↗ 0.09 (2.04%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
4.50
↗ 0.09 (2.04%)
🔴Market: CLOSED

Tao Synergies Inc. Common Stock (TAOX) trades at $4.41 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. TAOX is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$4.44
High?$4.80
Low?$4.34
Prev. Close?$4.39
Volume?246.6K
Avg. Volume?218.8K
VWAP?$4.54
Rel. Volume?1.13x
Bid / Ask
Bid?$4.43 × 100
Ask?$4.57 × 200
Spread?$0.14
Midpoint?$4.50
Valuation & Ratios
Market Cap?33.0M
Shares Out?7.5M
Float?7.2M
Float %?97.0%
P/E Ratio?N/A
P/B Ratio?2.59
EPS?-$2.95
Dividend?1.90%
Ex-Dividend?N/A
News
Profile
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Employees
4
Market Cap
33.0M
Industry
FINANCE SERVICES
Listed
2020-12-07
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
Phone: (973) 242-0005
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
50
Momentum?
50
Short Sent.?
49
Piotroski F-Score?0/9Weak
Confidence?35%Very Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.33%Elevated
Short Interest?459.1K
Days to Cover?4.2
Free Float7.2M
Avg Daily Volume110.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?19.99Strong
Quick Ratio?19.99Strong
Cash Ratio?2.30Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
63
2.59CHEAP▾
P/S?
Peers
100
S&P
3
42.72HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
39.65HIGH▾
Returns & Efficiency
ROE?
S&P
3
-173.1%WEAK▾
ROA?
S&P
3
-104.6%WEAK▾
Cash Flow & Enterprise
FCF?$-6203179
Enterprise Value?$30.6M
Fundamentals ratios updated end of day